Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents.
about
Microevolutionary analysis of Clostridium difficile genomes to investigate transmissionDiagnosis and treatment of acute or persistent diarrheaThe role of Clostridium difficile in the paediatric and neonatal gut - a narrative reviewClostridium difficile in the ICU: the struggle continuesClostridium difficile: epidemiology, diagnostic and therapeutic possibilities-a systematic reviewThe role of the healthcare environment in the spread of multidrug-resistant organisms: update on current best practices for containmentClostridium difficile infection: molecular pathogenesis and novel therapeuticsTracking Change: A Look at the Ecological Footprint of Antibiotics and Antimicrobial ResistanceLaboratory diagnosis of bacterial gastroenteritisClostridium difficile: A healthcare-associated infection of unknown significance in adults in sub-Saharan AfricaAsymptomatic Clostridium difficile colonization: epidemiology and clinical implicationsTranscriptional analysis of temporal gene expression in germinating Clostridium difficile 630 endosporesUnlocking the Sporicidal Potential of Ethanol: Induced Sporicidal Activity of Ethanol against Clostridium difficile and Bacillus Spores under Altered Physical and Chemical ConditionsTrends in Clostridium difficile Disease: Epidemiology and InterventionNosocomial transmission of C. difficile in English hospitals from patients with symptomatic infectionAsymptomatic Clostridium difficile colonisation and onward transmissionClostridium difficile infection: An overview of the disease and its pathogenesis, epidemiology and interventionsThe changing epidemiology of Clostridium difficile infectionsVirulence factor activity relationships (VFARs): a bioinformatics perspective.Survey of C. difficile-Specific Infection Control Policies in Local Long-Term Care FacilitiesIsolation of C. difficile Carriers Alone and as Part of a Bundle Approach for the Prevention of Clostridium difficile Infection (CDI): A Mathematical Model Based on Clinical Study Data.Triggering germination represents a novel strategy to enhance killing of Clostridium difficile spores.Clostridium difficile Infection: Epidemiology, Pathogenesis, Risk Factors, and Therapeutic Options.Influences on the start, selection and duration of treatment with antibiotics in long-term care facilities.Enhancing patient safety by reducing healthcare-associated infections: the role of discovery and dissemination.Characterisation and carriage ratio of Clostridium difficile strains isolated from a community-dwelling elderly population in the United Kingdom.Reconsidering the sporulation characteristics of hypervirulent Clostridium difficile BI/NAP1/027.The role of the humoral immune response to Clostridium difficile toxins A and B in susceptibility to C. difficile infection: a case-control study.Extraction and sensitive detection of toxins A and B from the human pathogen Clostridium difficile in 40 seconds using microwave-accelerated metal-enhanced fluorescence.Clostridium difficile carriage in elderly subjects and associated changes in the intestinal microbiotaA Clostridium difficile infection "intervention": change in toxin assay results in fewer C difficile infection cases without changes in patient outcomes.Clostridium: transmission difficile?Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing.Spores of Clostridium difficile clinical isolates display a diverse germination response to bile saltsCurrent status of Clostridium difficile infection epidemiologyClostridium difficile and the microbiotaImpact of toxigenic Clostridium difficile colonization and infection among hospitalized adults at a district hospital in southern Taiwan.Development of TaqMan-based quantitative PCR for sensitive and selective detection of toxigenic Clostridium difficile in human stools.Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in miceClostridium difficile 027 infection in Central Italy
P2860
Q21184007-AD1E9C5A-1252-45E7-BF1C-46F6D88E0223Q24654895-8FAFCAC5-1771-427C-A22E-B797888AE14BQ26750848-C6DC879A-8C4C-4B9E-93B6-ECA7931ED57CQ26823000-3B258A9F-769C-494E-B2D8-32D149069611Q26827693-9381DEC8-8AB7-435C-9BA8-D6A7D5815AABQ26829526-910CA6BE-2F29-440D-A21D-0E4E1876A86FQ26864237-DA8C8D7F-8CAC-4E01-BE6F-4C687BD26325Q27007076-A65DD361-E9A9-47D3-B574-ADF7E48C4EFBQ27027754-392DC14A-2BDC-4C27-BAB5-118972B607C4Q28077618-BC348EB0-D030-424A-813A-8C5BEC94F9F1Q28083860-F2FC1C46-D5F8-440F-BBAD-3B16AE301CEDQ28488073-A53783FE-ACC5-4462-A773-1156B21AB503Q28546550-9774AEE3-AAFD-4616-9D77-3D17136CF1CAQ28655729-DE6EA6F0-ED59-439B-A1E5-283B540D9C67Q28658118-32E9BD3B-15D9-4450-8B97-FE51D6AFE0E2Q28661623-6133C34F-5B69-40C6-BD62-330BAEC1ACFBQ28743438-6BCC26C4-7D20-4CBD-B17F-820F73F6B753Q28750385-CA8B8EEF-73C8-4506-9F09-54FEBC69938AQ30235426-6B90F37C-35A2-499F-8F24-AA94DCAE303AQ30412521-7910371B-6AC4-4426-93E4-8E500AA75CF4Q31105341-3E679C91-6772-4AD2-A190-B1CCB11575B6Q33680599-06F87D98-20A7-4E3E-B5C3-8B0CBA28B85FQ33759832-1BA4DAC6-E21E-4900-B098-083435115598Q33848870-026518AC-86D6-4CDB-9460-9E079B1B3202Q33988655-B78EC661-3ADA-4011-AF68-C4764EAF5173Q34008750-7C925691-569B-4797-8815-9C1FEA6BFF31Q34031580-4FADCBC6-3822-49FE-AC0B-908F32BAED52Q34074371-4DD2B8CB-A840-484E-9064-99B7EC07B783Q34097036-8CA28570-4633-4F23-8624-A889B87B2F1FQ34097514-8D616D6C-7C43-43CC-A355-C696D3299EA1Q34142574-5D0D77E8-FB1C-4271-AC69-CA6C76788DCAQ34162219-9E8BF2D6-64C1-4FFD-92AA-480C0C28942CQ34162226-80AE5E8D-9351-4CD3-8384-F43C3A5DD811Q34182639-F026BF8D-7963-4A63-B229-FC0D547F06D5Q34285444-5E5B4BEF-17F5-49F6-A84E-6CBD783F2BE3Q34311594-E058DB96-D098-4335-91D7-F37C3813A89DQ34372612-68377FCB-39EB-4965-8605-35A235B63507Q34435291-E2DAD394-F54B-4347-84BF-CBBC40F8C85FQ34468946-54DF7AEB-37F1-450A-9E71-A515ADD858F0Q34520307-17FB1A6C-463D-4062-95C9-821CDA1C38F0
P2860
Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Asymptomatic carriers are a po ...... -term care facility residents.
@ast
Asymptomatic carriers are a po ...... -term care facility residents.
@en
Asymptomatic carriers are a po ...... -term care facility residents.
@nl
type
label
Asymptomatic carriers are a po ...... -term care facility residents.
@ast
Asymptomatic carriers are a po ...... -term care facility residents.
@en
Asymptomatic carriers are a po ...... -term care facility residents.
@nl
prefLabel
Asymptomatic carriers are a po ...... -term care facility residents.
@ast
Asymptomatic carriers are a po ...... -term care facility residents.
@en
Asymptomatic carriers are a po ...... -term care facility residents.
@nl
P2093
P2860
P356
P1476
Asymptomatic carriers are a po ...... -term care facility residents.
@en
P2093
Ajay K Sethi
Elizabeth C Eckstein
Michelle M Riggs
Robin L P Jump
Trina F Zabarsky
P2860
P304
P356
10.1086/521854
P407
P577
2007-09-04T00:00:00Z